LUS, Giacomo
 Distribuzione geografica
Continente #
NA - Nord America 3.471
EU - Europa 2.972
AS - Asia 618
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 7.074
Nazione #
US - Stati Uniti d'America 3.454
IE - Irlanda 948
IT - Italia 487
UA - Ucraina 418
GB - Regno Unito 377
DE - Germania 264
SG - Singapore 252
CN - Cina 208
FR - Francia 135
FI - Finlandia 109
SE - Svezia 81
GR - Grecia 68
TR - Turchia 63
BE - Belgio 29
KR - Corea 24
HU - Ungheria 21
IR - Iran 19
CA - Canada 16
VN - Vietnam 14
HK - Hong Kong 12
IN - India 12
NL - Olanda 7
CH - Svizzera 5
CZ - Repubblica Ceca 4
AT - Austria 3
AU - Australia 3
BR - Brasile 3
ES - Italia 3
EU - Europa 3
IL - Israele 3
PK - Pakistan 3
PL - Polonia 3
RU - Federazione Russa 3
ID - Indonesia 2
JP - Giappone 2
NZ - Nuova Zelanda 2
RS - Serbia 2
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 7.074
Città #
Dublin 948
Santa Clara 623
Jacksonville 594
Chandler 578
Singapore 177
Ann Arbor 146
Princeton 143
Roxbury 112
Medford 99
Bremen 96
Caserta 87
Beijing 86
Boardman 68
Wilmington 58
Woodbridge 57
New York 54
Cambridge 50
Naples 43
San Mateo 39
Ashburn 32
Munich 31
Brussels 27
Norwalk 24
Milan 23
Des Moines 22
Seoul 22
Aversa 18
Houston 15
Dong Ket 14
Helsinki 14
Jinan 14
Los Angeles 14
Nanjing 14
Rome 13
Redwood City 11
Luzzano 10
Mountain View 10
Düsseldorf 9
Auburn Hills 8
Hong Kong 8
Siano 8
Tianjin 8
Napoli 7
Quarto 6
Taizhou 6
Nanchang 5
Reggio Nell'emilia 5
Salerno 5
Seattle 5
Shenyang 5
Toronto 5
Zhengzhou 5
Beauharnois 4
Boydton 4
Hangzhou 4
Hebei 4
Hyderabad 4
Lanzhou 4
Lappeenranta 4
Leawood 4
Ottawa 4
Reggio Emilia 4
San Giorgio A Cremano 4
Shanghai 4
Andover 3
Bari 3
Brno 3
Central District 3
Changchun 3
Columbus 3
Darmstadt 3
Dearborn 3
Guangzhou 3
Haikou 3
Karachi 3
Kunming 3
Philadelphia 3
Romentino 3
Sacramento 3
Venice 3
Vienna 3
Wroclaw 3
Zurich 3
Amsterdam 2
Belgrade 2
Carrara 2
Cava de' Tirreni 2
Changsha 2
Chennai 2
Chicago 2
Florence 2
Gunzenhausen 2
Istanbul 2
Lier 2
Limbiate 2
Marcianise 2
Ningbo 2
Otranto 2
Paris 2
Paulding 2
Totale 4.620
Nome #
INSOLITO PNEUMOCEFALO IPERTESO DA OSTEOMA DEL SENO FRONTALE 160
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 99
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 95
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 92
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 92
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients 91
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations 86
Biochemical and morphological evidences supporting the hypothesis of a role of Tgase in the pathogeneisi of Chorea-Acanthocytosis 76
Myoplasticity and myoregeneration; from molecular aspects to clinical perspectives 70
NEURO-DEGENERAZIONE CON ACCUMULO CEREBRALE DI FERRO TIPO 1 (NIBA TIPO1), UNA NUOVA FAMIGLIA CON MALATTIA DI HALLERVORDEN SPATZ A DECORSO CLINICO PROTRATTO 70
Chronic HCV infection and neurological and psychiatric disorders: an overview. 69
Malattie dei nervi periferici 69
Analisi in istofluorescenza di densità e distribuzione dei recettori per ConA e WGA in corso di rigenerazione e re-innervazione nel muscolo scheletrico di ratto ischemizzato e denervato, reversibilmente o irreversibilmente 69
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis 69
Myopathic changes in neurofibromatosis type 1 67
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 66
Retrospective epidemiology of Duchenne muscular dystrophy in Molise 65
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 65
Cecità e diplopia come espressione isolata di metastasi mesencefalica:considerazioni neuroradiologiche neurologiche e neurochirurgiche.A proposito di 2 casi 65
Reperti isto e citopatologici del tutto peculiari riscontrati in un caso familiare di sindrome della spina rigida 64
CECITÀ E DIPLOPIA COME ESPRESSIONE ISOLATA DI METASTASI MESENCEFALICHE: CONSIDERAZIONI NEURORADIOLOGICHE, NEUROLOGICHE E NEUROCHIRURGICHE A PROPOSITO DI DUE CASI” 64
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 64
Autoantibodies in multiple sclerosis patients before and during IFN-β1b treatment: Are they correlated with the occurrence of autoimmune diseases? 63
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 63
Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment. 62
Are giant axons a pathological marker of charcot-marie-tooth neuropathy type 2E? 62
La capacità rigenerativa del muscolo scheletrico danneggiato: studio sperimentale 62
CTG repeat number in the nonaffected allele of myotonic dystrophy patients is not critical for disease expression 61
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 61
A new tRNAHis mutation in the mtDNA results in mitochondrial encephalomyopathy by hampering ATP production 61
Animal model to study factors influencing regeneration and direct innervation or neurotization of skeletal muscle 61
LA NEUROMIELITE OTTICA È UN’ ASSOCIAZIONE SINDROMICA COMUNE A PATOLOGIE ETEROGENEE 61
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 61
Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. 60
An unusual phenotype of familial motor and sensory neuropathy with morphological features of HMSN1 60
CORRELATI CLINICO-STRUMENTALI IN UN CASO DI CREUTZFELD- JACOB A LUNGA SOPRAVVIVENZA. 60
Rasagiline improves sleep disorders in Parkinson's disease 60
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome 59
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 59
[Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome] 59
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 58
C’È UN GUADAGNO DIAGNOSTICO IN RM DELLE SACNSIONI TARDIVE OPO DOSE TRIPLA DI GADOLINIO NELL’IDENTIFICAZIONE DI PLACCHE ATTIVE DI SCLEROSI MULTIPLA? * Risultati preliminari 58
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 58
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 58
Unusual manifestation of vertebral osteoid osteoma: case report 57
Fluctuations of MS births and UV-light exposure. 56
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases 56
[Unusual histo-cytopathologic findings in a familial case of stiff spine syndrome] 56
Histopathological heterogeneity and cytopathological similarity of findings in different muscles of two brothers affected by rigid spine syndrome 56
39. Density and distribution of ConA and WGA receptors determined by histofluorescence analysis during degeneration, regeneration and reinnervation of the rat skeletal muscle following ischemia and reversible or irreversible denervation. , : , 56
Prognostic indicators in pediatric clinically isolated syndrome 56
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases 55
Dalla malattia di Schilder alla adrenoleucodistrofia: una breve storia di un secolo di ricerca neuropatologica clinica esemplare 55
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 55
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate 55
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 54
Progressive rubella panencephalitis. Follow-up EEG study of a case 54
NEURO-DEGENERAZIONE ASSOCIATA A PANTOTENATO- CHINASI (MALATTIA DI HALLERVORDEN – SPATZ) IN UNA FAMIGLIA ITALIANA: CORRELAZIONI CLINICHE,MRI E GENETICHE 54
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 53
Dalla malattia di Schilder all’adrenoleucodistrofia; una breve storia di un secolo di ricerca neuropatologica clinica esemplare 52
AZATIOPRINA E INTERFERONE - 1° NEI PAZIENTI CON SCLEROSI MULTIPLA RECIDIVANTE REMITTENTE: INCREMENTO DELL’EFFICACIA DEL TRATTAMENTO COMBINATO. 52
A cluster of progranulin C157KfsX97 mutation in southern Italy- clinical characterization and genetic correlations 52
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders 51
Malattie mono e plurisistemiche 51
Rigenerazione e reinnervazione del muscolo scheletrico di ratto ischemizzato e, reversibilmente o irreversibilmente, denervato: osservazioni in istofluorescenza della densità e distribuzione dei recettori per ConA e WGA 51
Monitoraggio biologico e sorveglianza sanitaria ai lavoratori esposti a bromuro di metile 51
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 51
Neutralizing antibodies in multiple sclerosis patients treated with 375 microg interferon-beta-1b 50
Familial idiopatic hyperCKemia: changes of muscle biopsy in 8 cases 49
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 49
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 49
Muscular regeneration and reinnervation or neurotization in control, preinjured or dystrophic animals 48
The Italian multiple sclerosis register 48
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 48
Malattie multisistemiche 47
Variability of muscle findings in rigid spine syndrome. : , 46
EFFICACIA E TOLLERABILITÀ DEL TRATTAMENTO A LUNGO TERMINE CON AZATIOPRINA NELLA SCLEROSI MULTIPLA RECIDIVANTE-REMITTENTE: UNO STUDIO PROSPETTICO 46
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 46
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 46
Central pontine myelinolisis- case report 45
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 45
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 44
Malattie del muscolo 44
Malattia demielizzante in un bambino: contributo diagnostico della RM. 44
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study 44
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke 44
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 44
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches 43
Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy 43
Malattie della giunzione neuromuscolare 43
Histochemical, cytochemical and biochemical observations in orthotopic homotransplants of EDL in adult rats 43
Mitochondrial myopathy and Marfan-like clinical pattern 43
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 43
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis 42
Migraine as possible red flag of PFO presence in suspected demyelinating disease 42
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 42
Disability assessment using Google Maps 42
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis 41
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 41
Hyperckemia in the neuroacanthocytosis: possible tissutal transglutaminase abnormality in skeletal muscle 40
Totale 5.767
Categoria #
all - tutte 33.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 0 0 0 0 0 20 140 27 39 58 48 17
2020/20211.026 185 13 101 54 149 17 130 102 22 122 88 43
2021/20221.067 52 132 10 27 292 9 27 34 37 68 97 282
2022/20232.026 171 36 32 185 240 179 2 134 923 20 60 44
2023/2024743 70 21 48 56 252 60 10 25 14 3 59 125
2024/2025981 6 46 40 75 414 400 0 0 0 0 0 0
Totale 7.466